Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[BVDU therapy in herpes corneae].

A Benad1, E Richter

  • 1Klinik für Augenheilkunde des Bereiches Medizin, Wilhelm-Pieck-Universität Rostock.

Klinische Monatsblatter Fur Augenheilkunde
|June 1, 1989
PubMed
Summary

A pilot study found that 0.1% BVDU eye drops effectively treated keratitis in 82.5% of patients within 14 days. This antiviral therapy demonstrated good tolerance and rapid healing for most participants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outbreak of Tuberculosis in a Colony of Rhesus Monkeys (Macaca mulatta) after Possible Indirect Contact with a Human TB Patient.

Journal of comparative pathology·2015
Same author

[Current microbiological methods in the investigation of mycobacteria].

Pneumologie (Stuttgart, Germany)·2015
Same author

Efficacy and safety of nicoboxil/nonivamide ointment for the treatment of acute pain in the low back - A randomized, controlled trial.

European journal of pain (London, England)·2015
Same author

Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.

Drug research·2015
Same author

Erratum to: Quality assessment of digested sludges produced by advanced stabilization processes.

Environmental science and pollution research international·2015
Same author

Inactivation of Mycobacterium bovis ssp. caprae in high-temperature, short-term pasteurized pilot-plant milk.

Journal of dairy science·2015

Area of Science:

  • Ophthalmology
  • Virology
  • Pharmacology

Context:

  • Pilot study evaluating a novel antiviral agent for ocular infections.
  • Focus on patients with various forms of keratitis, including stellate, dendritic, and geographic patterns.
  • Assessment of therapeutic efficacy and patient tolerance.

Purpose:

  • To investigate the effectiveness and safety of 0.1% BVDU eye drops in treating keratitis.
  • To determine the healing time and re-epithelialization rates in patients receiving BVDU therapy.
  • To evaluate the overall success rate of BVDU for ocular surface disease.

Summary:

  • The study involved 80 patients with keratitis treated with 0.1% BVDU eye drops.
  • A significant majority (82.5%) experienced healing within 14 days, with an average re-epithelialization time of 5.4 days.
  • Treatment failure was observed in 16.3% of patients, and one patient discontinued due to adverse effects.

Impact:

  • 0.1% BVDU eye drops show promising results as a well-tolerated treatment for keratitis.
  • The findings suggest BVDU as a potential therapeutic option for specific viral ocular infections.
  • Further research may validate these findings in larger patient cohorts.

Related Experiment Videos